Cargando…
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
BACKGROUND: Pioglitazone was used to treat patients of PCOS in many researches, but the treatment has not been recognized by public or recommended by all the guidelines. METHOD: We conducted a meta-analysis of the related literatures to objectively evaluate the clinical effectiveness and safety by c...
Autores principales: | Xu, Yifeng, Wu, Yanxiang, Huang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591817/ https://www.ncbi.nlm.nih.gov/pubmed/28770353 http://dx.doi.org/10.1007/s00404-017-4480-z |
Ejemplares similares
-
Metformin-Clinical Pharmacology in PCOs
por: Dumitrescu, R, et al.
Publicado: (2015) -
ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022) -
Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016) -
The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis
por: Yuan, Lifang, et al.
Publicado: (2021) -
Simultaneous Estimation of Metformin and Pioglitazone by Ultraviolet Spectrophotometry
por: Goswami, Laxmi, et al.
Publicado: (2010)